Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Henderson Cuts Stake In Jubilant Organosys
Henderson Equity Partners has made a partial exit from its five-and-half-year-old investment in drug and chemical makers Jubilant Organosys. The ......
Healthcare
Fortis May Become A Subsidiary Of Parkway Holdings
Brothers Malvinder and Shivinder Singh plan to make Fortis Healthcare a subsidiary of Parkways once the company successfully acquires Singapore-based ......
Healthcare
Fortis Makes Counter Offer At SGD 3.78/Share For Parkway
Fortis Healthcare Ltd, which is in battle with Khazanah Nasional Bhd to acquire Singapore-based Parkway Holdings Ltd, made a counter ......
Healthcare
A Lukewarm Listing Debut For BTS India-Backed Parabolic Drugs
BTS India Private Equity-backed pharmaceutical firm Parabolic Drugs has made a disappointing debut on the stock exchange. Although the scrip ......
Healthcare
Pharma Firms Demerging Domestic Biz; Eyeing Better Valuation
With multinational pharma companies scouring for deals to tap the Rs 41,000-crore Indian pharma market, domestic firms are actively exploring ......
Healthcare
Times Private Treaties Inks Pact With Novartis India
Times Private Treaties, the ad-for-equity investment arm of media house Bennett, Coleman & Company Ltd, has entered into a 'strategic ......
Healthcare
AstraZeneca India To De-list From Bourses
AstraZeneca Pharma India, Indian arm of Sweden-based AstraZeneca Pharmaceuticals AB, will de-list itself from domestic stock exchanges, BSE, NSE and ......
Healthcare
Alembic To De-merge Core Pharma Business
Alembic Limited has decided to de-merge its core pharmaceutical business into a 100% subsidiary company called Alembic Pharma Limited. As ......
Healthcare
ICICI Venture May Sell I-Ven Pharma To SPV Partner Dr Reddy's
ICICI Venture, India's largest private equity player, is looking at selling I-Ven Pharma Capital Limited, a Special Purpose Vehicle, to ......
Healthcare
GIC Singapore To Defer Rs 380Cr Infusion In Fortis
GIC Special Investments--the private equity arm of Singapore Government's GIC—has announced that it will defer its Rs 380-crore investment in ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News